Coloring curable resin composition, cured film, color filter, method for manufacturing color filter, solid-state imaging device, image display device, compound, and cation
US-2016376234-A1 · Dec 29, 2016 · US
Oligomer-amino acid conjugates
US9487473B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9487473-B2 |
| Application number | US-201514920554-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 22, 2015 |
| Priority date | Feb 24, 2009 |
| Publication date | Nov 8, 2016 |
| Grant date | Nov 8, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention relates to (among other things) oligomer-amino acid conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over un-conjugated amino acid compounds.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound having the following structure: wherein n is an integer from 1 to 30. 2. The compound of claim 1 , wherein n is an integer from 1 to 10. 3. The compound of claim 1 , wherein n is 2. 4. The compound of claim 1 , wherein n is 3. 5. The compound of claim 1 , wherein n is 4. 6. The compound of claim 1 , wherein n is 5. 7. The compound of claim 1 , wherein n is 6. 8. The compound of claim 1 , wherein n is 7. 9. The compound of claim 1 , wherein n is 8. 10. The compound of claim 1 , wherein n is 9. 11. The compound of claim 1 , wherein n is 10. 12. The compound of claim 1 , wherein n is 11. 13. A composition comprising a compound of claim 1 , and optionally, a pharmaceutically acceptable excipient. 14. A composition of matter comprising a compound of claim 1 , wherein the compound is present in a dosage form.
Assignees
Inventors
Classifications
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
- C07C229/48Primary
with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring · CPC title
The ring being saturated · CPC title
Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia · CPC title
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9487473B2 cover?
- The invention relates to (among other things) oligomer-amino acid conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over un-conjugated amino acid compounds.
- Who is the assignee on this patent?
- Nektar Therapeutics
- What technology area does this patent fall under?
- Primary CPC classification C07C229/48. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).